Skip to main content
. 2021 Apr 24;12(12):3548–3557. doi: 10.7150/jca.50292

Figure 1.

Figure 1

Lenvatinib inhibited proliferation and colony formation in GBC-SD and NOZ cells. GBC-SD and NOZ cells were treated with different concentrations of lenvatinib for 24, 48 and 72 h. (A and B) Cell viability was examined by Cell Counting Kit-8 assay. (C) Colony formation. *P<0.05 vs. 0 µM. NC, negative control.